TY - JOUR TI - Inhibition of retinoic acid receptor α phosphorylation represses the progression of triple-negative breast cancer via transactivating miR-3074-5p to target DHRS3 AU - Lou, Siyue AU - Gao, Hang AU - Hong, Huanwu AU - Zhu, Zhihui AU - Zhao, Huajun T2 - Journal of Experimental & Clinical Cancer Research AB - Retinoids are promising agents in the treatment of different types of neoplasia including estrogen receptor-positive breast cancers, whereas refractoriness/low sensitivity is observed in triple-negative breast cancer (TNBC) subtype. However, the reason for these diverse retinoid-sensitivity remains elusive. DA - 2021/04/26/ PY - 2021 DO - 10.1186/s13046-021-01941-7 DP - BioMed Central VL - 40 IS - 1 SP - 141 J2 - Journal of Experimental & Clinical Cancer Research SN - 1756-9966 UR - https://doi.org/10.1186/s13046-021-01941-7 Y2 - 2021/04/28/22:50:59 KW - DHRS3 KW - Phosphorylation KW - RARα KW - Triple-negative breast cancer KW - miR-3074-5p ER -